Navigation Links
Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results
Date:2/3/2009

risks related to Rigel's need for additional capital. These and other risk factors are discussed under "Risk Factors" in Rigel's SEC reports, including its Form 10-Q for the quarter ended September 30, 2008. Rigel undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in its expectations.

     Contact: Raul Rodriguez
     Phone: 650.624.1302
     Email: invrel@rigel.com

     Media Contact: Susan C. Rogers, Alchemy Consulting, Inc.
     Phone: 650.430.3777
     Email: susan@alchemyemail.com

'/>"/>
SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Rigels R788 Phase 2a Results Published in Arthritis and Rheumatism
2. Rigel to Host Conference Call to Discuss Preliminary Phase 2 Study Results of R788 in Lymphoma
3. Rigels R788 Slows Progression of Murine Lupus in Preclinical Studies
4. Rigels R788 Shows Preclinical Activity in Type 1 Diabetes Model
5. Rigel Announces Initiation of Phase 1 Clinical Trial of R348 for Rheumatoid Arthritis, Psoriasis and Other Immune Disorders
6. Rigels R788 Demonstrates Significant Improvement in Rheumatoid Arthritis in Phase 2 Clinical Study
7. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
8. CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008
9. Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October
10. The Leukemia & Lymphoma Society and Celator Pharmaceuticals Announce Partnership to Accelerate Development of CPX-351 for AML
11. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... 30, 2015  NanoSmart Pharmaceuticals, Inc., a private ... received Orphan Drug Designation from the Food and ... that uses NanoSmart,s proprietary drug delivery platform. The ... the treatment of Ewing,s sarcoma, a rare type ... Orphan Drug Designation on the basis of a ...
(Date:7/30/2015)... July 30, 2015 /PRNewswire/ - Anything Technologies Media, Inc. ... Frontier Indoor Garden Solutions (FIGS), www.frontiergarden.com ... and the Project Manager for a My Compassion ... American Group located in Alaska.  The project will ... its finance Teaming Partners. The first phase of ...
(Date:7/30/2015)... 2015  Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) ... webcast at 5:00 p.m. Eastern Time (2:00 p.m. Pacific ... quarter 2015 financial results and provide a corporate update. ... Global Select Market closes that day. The ... domestic callers and 914.495.8552 for international callers. Please specify ...
Breaking Medicine Technology:NanoSmart Receives Second FDA Orphan Drug Designation for Treatment of Pediatric Cancer 2Frontier Indoor Garden Solutions announced as Horticultural Supplier and Project Manager for Alaskan Tribal Medical Marijuana Grow Facility 2Frontier Indoor Garden Solutions announced as Horticultural Supplier and Project Manager for Alaskan Tribal Medical Marijuana Grow Facility 3Arena Pharmaceuticals to Host Second Quarter 2015 Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 5 2Arena Pharmaceuticals to Host Second Quarter 2015 Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 5 3Arena Pharmaceuticals to Host Second Quarter 2015 Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 5 4
... Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR ) today announced ... Health Care Conference. Piper Jaffray Health Care Conference ... 2:00 p.m. ET A ... at http://www.avanir.com . About Avanir Pharmaceuticals, ...
... 2011  Cara Therapeutics, Inc. today announced the initiation ... an oral formulation of its peptide-based, kappa opioid ... trial is expected to enroll up to 60 ... evaluate the pharmacokinetic, pharmacodynamic and safety profile of ...
Cached Medicine Technology:Cara Therapeutics Initiates Phase I Study with Oral Formulation of Novel Peripherally-Acting Kappa Opioid Agonist 2
(Date:7/30/2015)... ... 30, 2015 , ... Ross A. Clevens, MD, FACS has been ... of Plastic Surgery. This is Dr. Clevens’ second appointment by the prestigious school. ... developing a strong presence and a valuable mentoring program for medical students. ...
(Date:7/30/2015)... ... July 30, 2015 , ... Western University of Health Sciences ... Special Olympics World Games, the largest sports and humanitarian event in the world this ... , The World Games, held July 25 through August 2, 2015, benefited from the ...
(Date:7/30/2015)... ... 30, 2015 , ... Ocean Hills Recovery has officially been accredited by CARF ... No recommendations means CARF found no areas in the OHR program that needed improvement, ... of all facilities receive. In addition, Ocean Hills was granted the maximum certification period ...
(Date:7/30/2015)... ... 30, 2015 , ... New research finds some distinct differences in the way ... on the Surviving Mesothelioma website. , Researchers with the National Institutes of Health, ... cases of mesothelioma occurring between 1990 and 2010. Two percent of these cases (207) ...
(Date:7/30/2015)... ... 30, 2015 , ... Political unrest is the number one ... new survey by leading international insurance provider Clements Worldwide. The "Clements Worldwide Risk ... the largest sources of financial losses among respondents. , Twenty-eight percent of top ...
Breaking Medicine News(10 mins):Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 2Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 3Health News:WesternU Makes Big Impact at Special Olympics 2Health News:WesternU Makes Big Impact at Special Olympics 3Health News:Ocean Hills Recovery Receives Accreditation from CARF International 2Health News:Study Finds Mesothelioma Behaves Differently in Younger People, According to Surviving Mesothelioma 2Health News:New Clements Worldwide Global Risk Survey Shows Political Risk and Instability Top Managers' Concerns 2Health News:New Clements Worldwide Global Risk Survey Shows Political Risk and Instability Top Managers' Concerns 3
... blood sugar namely blindness, malfunction of the kidneys are known. ... have now come out with astonishing details that a raise ... than 100 adults with type 1 diabetes hwo had four ... mouth, having a sweet taste in their mouth and needing ...
... the globe as 95% of the AIDS victims dwell ... Special Session on HIV/AIDS, physicians demanded to bring down ... the AIDS victims in developing countries. ,Dr. Anne-Valerie ... as Medicines Sans Frontieres, or MSF), MSF provides healthcare ...
... Heart Association's 41st Annual Conference on Cardiovascular Disease Epidemiology ... new cousin counterpart to heart disease-Asthma. It is found ... ,Carlos Iribarren, MD, MPH, PhD, of Kaiser Permanente, in ... had a risk of 33% towards developing the heart ...
... number of psychological benefits, including fighting stress-related physical and ... found no psychological benefit from the use of ginseng. ... the sport and exercise psychology lab at the Oregon ... Engles, PhD, conducted the study and found that there ...
... the major cause of morbidity in most of the ... reluctant to take extra vitamins or iron pills, as ... were effective for improving the iron status of young ... iron deficiency in children of low-to-middle income groups. These ...
... is an inherited disease of the nervous system due ... causing symptoms such as involuntary movements and balance problems ... speech as well. ,All these days, until now, ... a mutated form of the protein 'huntingtin' which is ...
Cached Medicine News:Health News:Asthma! A new warning for heart disease 2
Reptilase-Time from Bothrops atrox...
Pefakit PiCT UFH Controls...
Pefakit PiCT LMWH Calibrators...
APTT (Ellagic Acid) - 10 ml...
Medicine Products: